News

Press Releases and news in Swedish/English can be found here.

AcuCort announces that the registration process in the Nordic market is underway for the company’s drug ISICORT®

15 november, 2021

AcuCort AB (Spotlight Stock Market: ACUC) announced today that the registration process in Denmark, Finland, Iceland and Norway... [Läs mer]

AcuCort’s drug ISICORT® demonstrates a three-year shelf life

5 oktober, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the company’s drug ISICORT® has demonstrated a three-year shelf... [Läs mer]

AcuCort receives a second US patent protection for its drug ISICORT®

3 september, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announces that the US Patent and Trademark Office, USPTO, has announced... [Läs mer]

AcuCort to present at events arranged by Aktiespararna

23 augusti, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the company’s CEO Jonas Jönmark will participate and present... [Läs mer]

AcuCort announces that the Board of Directors and the CEO have subscribed for options to purchase shares in the company

11 augusti, 2021

AcuCort AB (Spotlight Stock Market: ACUC) announces that the Board of Directors and the CEO have subscribed for... [Läs mer]

AcuCort progresses into a new phase and strengthens the commercialization team

26 april, 2021

AcuCort AB (Spotlight Stock Market: ACUC) has employed Louise Harting as Project Manager. The company has entered a... [Läs mer]

AcuCort AB (publ) publishes its Annual Report January 1, 2020 – December 31, 2020

6 april, 2021

AcuCort AB’s Annual Report 2020 (in Swedish). [Läs mer]

AcuCort: Granted patent in Japan for the company’s drug ISICORT®

30 mars, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the Japan Patent Office (JPO) has granted a patent... [Läs mer]

AcuCort is granted trademark protection in the US for its drug ISICORT®

3 mars, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the United States Patent and Trademark Office (USPTO) has... [Läs mer]

AcuCort’s drug ISICORT® is approved for treatment of COVID-19

3 februari, 2021

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the Swedish Medical Products Agency has granted the company’s... [Läs mer]